BSE Live
Jan 21, 16:01Prev. Close
3974.90
Open Price
3959.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:47Prev. Close
3976.80
Open Price
3960.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3981.80 (98)
| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 25.01 | 30.33 | |
| Diluted EPS (Rs.) | 25.01 | 30.33 | |
| Cash EPS (Rs.) | 33.60 | 37.75 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 161.09 | 145.20 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 161.09 | 145.20 | |
| Dividend / Share(Rs.) | 8.00 | 8.00 | |
| Revenue from Operations/Share (Rs.) | 225.72 | 216.52 | |
| PBDIT/Share (Rs.) | 39.13 | 49.94 | |
| PBIT/Share (Rs.) | 30.53 | 42.52 | |
| PBT/Share (Rs.) | 28.77 | 42.26 | |
| Net Profit/Share (Rs.) | 25.01 | 30.33 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 17.33 | 23.06 | |
| PBIT Margin (%) | 13.52 | 19.63 | |
| PBT Margin (%) | 12.74 | 19.51 | |
| Net Profit Margin (%) | 11.08 | 14.00 | |
| Return on Networth / Equity (%) | 15.52 | 20.89 | |
| Return on Capital Employed (%) | 9.14 | 18.35 | |
| Return on Assets (%) | 7.17 | 14.48 | |
| Total Debt/Equity (X) | 0.62 | 0.00 | |
| Asset Turnover Ratio (%) | 64.71 | 103.42 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.60 | 1.90 | |
| Quick Ratio (X) | 0.69 | 0.89 | |
| Inventory Turnover Ratio (X) | 3.29 | 4.84 | |
| Dividend Payout Ratio (NP) (%) | 31.97 | 26.37 | |
| Dividend Payout Ratio (CP) (%) | 23.80 | 21.19 | |
| Earnings Retention Ratio (%) | 68.03 | 73.63 | |
| Cash Earnings Retention Ratio (%) | 76.20 | 78.81 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 1,134.23 | 679.38 | |
| EV/Net Operating Revenue (X) | 2.38 | 1.48 | |
| EV/EBITDA (X) | 13.70 | 6.43 | |
| MarketCap/Net Operating Revenue (X) | 1.95 | 1.50 | |
| Retention Ratios (%) | 68.02 | 73.62 | |
| Price/BV (X) | 2.73 | 2.24 | |
| Price/Net Operating Revenue | 1.95 | 1.50 | |
| Earnings Yield | 0.06 | 0.09 |
09.01.2026
05.12.2025
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012